Trial Profile
A Randomized, Double-Blind, Placebo-Controlled Study to Assess the Efficacy and Safety of Intra-Articular metHuIL-1ra (Anakinra) in Subjects With Osteoarthritis (OA) of the Knee.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 08 Jul 2017
Price :
$35
*
At a glance
- Drugs Anakinra (Primary)
- Indications Musculoskeletal pain; Osteoarthritis
- Focus Therapeutic Use
- 15 Mar 2009 Results published in Arthritis & Rheumatism.
- 31 Oct 2005 New trial record.